0001661539-22-000005.txt : 20220203
0001661539-22-000005.hdr.sgml : 20220203
20220203173641
ACCESSION NUMBER: 0001661539-22-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trevejo Jose M.
CENTRAL INDEX KEY: 0001661539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 22589898
MAIL ADDRESS:
STREET 1: C/O VISTERRA, INC.
STREET 2: ONE KENDALL SQUARE, #B3301
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wf-form4_164392778280060.xml
FORM 4
X0306
4
2022-02-01
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001661539
Trevejo Jose M.
15540 LAGUNA CANYON ROAD
SUITE 160
IRVINE
CA
92618
0
1
0
0
CHIEF MEDICAL OFFICER
Employee Stock Option (right to buy)
20.64
2022-02-01
4
A
0
116424
0
A
2032-01-31
Common Stock
116424.0
116424
D
Restricted Stock Units
2022-02-01
4
A
0
30197
0
A
Common Stock
30197.0
30197
D
25% of the option shares shall vest on February 1, 2023, and 1/48th of the option shares shall vest each month thereafter for a period of 3 years subject to the Reporting Person's continuous service.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
25% of the RSUs will vest on March 15th of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service.
/s/ Leonard M. Greenstein
2022-02-03